466 related articles for article (PubMed ID: 16325931)
1. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
[TBL] [Abstract][Full Text] [Related]
2. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus DNA replication: antiviral targets and drugs.
Mercorelli B; Sinigalia E; Loregian A; Palù G
Rev Med Virol; 2008; 18(3):177-210. PubMed ID: 18027349
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.
Schnepf N; Corvo J; Pors MJ; Mazeron MC
Antiviral Res; 2011 Feb; 89(2):186-8. PubMed ID: 21167209
[TBL] [Abstract][Full Text] [Related]
5. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
Shapira MY; Resnick IB; Chou S; Neumann AU; Lurain NS; Stamminger T; Caplan O; Saleh N; Efferth T; Marschall M; Wolf DG
Clin Infect Dis; 2008 May; 46(9):1455-7. PubMed ID: 18419454
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of human CMV.
Andrei G; De Clercq E; Snoeck R
Curr Opin Investig Drugs; 2008 Feb; 9(2):132-45. PubMed ID: 18246516
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
Michaelis M; Ha TA; Doerr HW; Cinatl J
Cardiovasc Res; 2008 Feb; 77(3):544-50. PubMed ID: 18006438
[TBL] [Abstract][Full Text] [Related]
8. Effects of allitridin on acute and chronic mouse cytomegalovirus infection.
Liu XL; Wang H; Li YN; Ge HX; Shu SN; Fang F
Arch Virol; 2011 Oct; 156(10):1841-6. PubMed ID: 21604182
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.
Efferth T; Marschall M; Wang X; Huong SM; Hauber I; Olbrich A; Kronschnabl M; Stamminger T; Huang ES
J Mol Med (Berl); 2002 Apr; 80(4):233-42. PubMed ID: 11976732
[TBL] [Abstract][Full Text] [Related]
10. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
[TBL] [Abstract][Full Text] [Related]
11. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.
Luganini A; Giuliani A; Pirri G; Pizzuto L; Landolfo S; Gribaudo G
Antiviral Res; 2010 Mar; 85(3):532-40. PubMed ID: 20083141
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.
Schnepf N; Boiteau N; Petit F; Alain S; Sanson-Le Pors MJ; Mazeron MC
Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772
[TBL] [Abstract][Full Text] [Related]
13. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.
Akuzawa K; Yamada R; Li Z; Li Y; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
Antiviral Res; 2011 Sep; 91(3):296-303. PubMed ID: 21745500
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate.
Milbradt J; Auerochs S; Korn K; Marschall M
J Clin Virol; 2009 Sep; 46(1):24-8. PubMed ID: 19501020
[TBL] [Abstract][Full Text] [Related]
16. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
Kern ER; Rybak RJ; Hartline CB; Bidanset DJ
Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
20. Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
Drouot E; Piret J; Boivin G
Antivir Ther; 2016; 21(6):535-539. PubMed ID: 26844400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
